5-(TETRADECYLOXY)-2-FUROIC ACID CAS#: 54857-86-2; ChemWhat Code: 848422

IdentificationPhysical DataSpectra
Route of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product Name5-(TETRADECYLOXY)-2-FUROIC ACID
IUPAC Name5-tetradecoxyfuran-2-carboxylic acid
Molecular StructureStructure of 5-(TETRADECYLOXY)-2-FUROIC ACID CAS# 54857-86-2
CAS Registry Number 54857-86-2
EINECS NumberNo data available
MDL NumberMFCD01726059
Beilstein Registry NumberNo data available
Synonyms5-(tetradecyloxy)-2-furancarboxylic acid5-(tetradecyloxy)-2-furoic acidTOFA
Molecular FormulaC19H32O4
Molecular Weight324.45
InChIInChI=1S/C19H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22-18-15-14-17(23-18)19(20)21/h14-15H,2-13,16H2,1H3,(H,20,21)
InChI KeyCZRCFAOMWRAFIC-UHFFFAOYSA-N
Canonical SMILESCCCCCCCCCCCCCCOc1ccc(o1)C(=O)O
Patent Information
Patent IDTitlePublication Date
WO2022/5871METHODS OF TREATING SARS-COV-2 INFECTION USING INHIBITORS OF LIPOGENESIS2022
US2016/229825SYNTHETIC PROCESS FOR PREPARING 2-FUROIC ACID DERIVATIVES2016
US4110351Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts1978

Physical Data

AppearanceWhite to beige powder
SolubilityDMSO: 2.5 mg/mL
Flash PointNo data available
Refractive indexNo data available
SensitivityNo data available
Melting Point, °C
119
117 – 120

Spectra

Description (NMR Spectroscopy)
NMR
5-(TETRADECYLOXY)-2-FUROIC ACID CAS#: 54857-86-2 NMRHNMR of 5-(Tetradecyloxy)-2-furoic acid (TOFA) CAS 54857-86-2
Description (IR Spectroscopy)
IR
Description (UV/VIS Spectroscopy)
UV/VIS
5-(TETRADECYLOXY)-2-FUROIC ACID CAS#: 54857-86-2 LCMSLCMS-1 of 5-(Tetradecyloxy)-2-furoic acid (TOFA) CAS 54857-86-2LCMS-2 of 5-(Tetradecyloxy)-2-furoic acid (TOFA) CAS 54857-86-2LCMS-3 of 5-(Tetradecyloxy)-2-furoic acid (TOFA) CAS 54857-86-2

Route of Synthesis (ROS)

Route of Synthesis (ROS) of 5-(TETRADECYLOXY)-2-FUROIC ACID CAS 54857-86-2
Route of Synthesis (ROS) of 5-(TETRADECYLOXY)-2-FUROIC ACID CAS 54857-86-2
ConditionsYield
Stage #1: 5-(tetradecyloxy)-2-furancarboxylic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 0 – 20℃;
Stage #2: salicylic acid With triethylamine In dichloromethane at 0℃; for 2h;
57%

Safety and Hazards

GHS Hazard StatementsNot Classified
For more detailed information, please visit ECHA C&L website
Source: European Chemicals Agency (ECHA)
License Note: Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: “Source: European Chemicals Agency, http://echa.europa.eu/”. Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
License URL: https://echa.europa.eu/web/guest/legal-notice
Record Name: (1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate
URL: https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/213446
Description: The information provided here is aggregated from the “Notified classification and labelling” from ECHA’s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database

Other Data

TransportationUnder the room temperature and away from light
HS CodeNo data available
StorageStore at 2-5℃, keep in dry and aovid direct sun light.
Shelf Life2 years
Market PriceUSD
Druglikeness
Lipinski rules component
Molecular Weight324.461
logP7.784
HBA2
HBD1
Matching Lipinski Rules3
Veber rules component
Polar Surface Area (PSA)59.67
Rotatable Bond (RotB)15
Matching Veber Rules1
Use Pattern
identifying a MYC-driven neoplasm therapeutic agent
inhibitor of ACACA
treating MYC-driven neoplasm
treating a subject for a lipogenesis-dependent neoplasm

Buy Reagent

No reagent supplier? Send quick inquiry to ChemWhat
Want to be listed here as a reagent supplier? (Paid service) Click here to contact ChemWhat

Approved Manufacturers

Watson Bio Ltd https://www.watson-bio.com/
Want to be listed as an approved manufacturer (Requires approvement)? Please download and fill out this form and send back to approved-manufacturers@chemwhat.com

Contact Us for Other Help

Contact us for other information or services Click here to contact ChemWhat